Egin Research

High Wycombe, United Kingdom Founded: 2019 • Age: 7 yrs Acquired By Velocity Clinical Research
Provider of clinical trial research and patient recruitment services for pharmaceutical industry

About Egin Research

Egin Research is a Healthcare company based in High Wycombe (United Kingdom) founded in 2019, and was acquired by Velocity Clinical Research in November 2022. Provider of clinical trial research and patient recruitment services for pharmaceutical industry. Its focus areas include Biopharma Outsourcing, Diversified, Services for Healthcare Providers and Patient Engagement.

Company details

Egin Research was established in 2019 and is headquartered in High Wycombe, United Kingdom. Clinical trial and research support, including patient recruitment, are delivered to pharmaceutical companies. Operations center on facilitating efficient trial processes and participant engagement within the sector. Services are tailored to meet industry needs for reliable research outcomes and recruitment strategies, with a focus on the European market.

  • Headquarters High Wycombe, United Kingdom
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website eginresearch.com
  • Social LinkedIn X Facebook
  • Acquired by Velocity Clinical Research (Nov 2022)
Key Metrics

Investors in Egin Research

Egin Research has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Velocity Clinical Research.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Provider of site management and patient recruitment services
2017velocityclinical.comDurham, United States
Premium access

Investor details for Egin Research

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Egin Research

2 dated milestones of Egin Research across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Egin Research is founded.
  2. Exit Acquired by Velocity Clinical Research.

Web traffic of Egin Research

The website of Egin Research (eginresearch.com) receives about 1.5K visits a month.

  • Monthly visits
    1.5K
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Egin Research

Premium access

Complete news archive for Egin Research

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Egin Research

Egin Research was founded in 2019.

Egin Research is headquartered in High Wycombe, United Kingdom. It is registered at High Wycombe, Buckinghamshire, United Kingdom.

Egin Research was established in 2019 and is headquartered in High Wycombe, United Kingdom. Clinical trial and research support, including patient recruitment, are delivered to pharmaceutical companies. Operations center on facilitating efficient trial processes and participant engagement within the sector. Services are tailored to meet industry needs for reliable research outcomes and recruitment strategies, with a focus on the European market.

Egin Research has 1 investor. Key investors include Velocity Clinical Research.

Yes. Egin Research was acquired by Velocity Clinical Research in November 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available